Recent posts

Oligo-mania! Interest in Oligonucleotides Continues to Rise

By July 7, 2017

From oligonucleotides and peptides to messenger RNA and CRISPR, ’tides are enjoying their time in the sun A year ago we wrote how oligonucleotide therapeutic development, which had seen a huge wave of investment in… Read more >

Categories: Pharmaceutical
Tags: , , , , ,

A Leading CRO’s Customer Focus Leads to Improvements in Quality and Productivity

By April 25, 2017

“One of the important reasons that we use Waters LC-MS instruments is that beyond the quality of the products, Waters delivers a high degree of technical training. This provides us with the knowledge and confidence that we can solve our complex research questions.” comments Triskelion’s Richard Bas.

Categories: Pharmaceutical
Tags: , , , , , , , ,

A CRO Leads the Way for Biotherapeutics Amid its Own ‘Field of Dreams’

By January 16, 2017

“If You Build it, He Will Come” Urged on by a voice no one else could hear, Ray Kinsella, played by Kevin Costner in the movie Field of Dreams, cleared a few acres of corn… Read more >

Categories: Pharmaceutical
Tags: , , ,

Analytical Tools for Developing Biosimilars: Part 3, Glycosylation, Aggregation, and Charge Variants

By January 13, 2017

In biotherapeutics, the state of glycosylation has a direct and pronounced effect of the structure, stability, serum half-life, immunogeneicity and bioactivity of the molecule, and constitutes a critical quality attribute (CQA). In our study, characterizing and comparing the glycosylation profile of infliximab began by examining the glycosylation profiles from intact and reduced subunit mass data.

Categories: Pharmaceutical
Tags: , , , , , , , , , , ,

Analytical Tools for Developing Biosimilars: Part 2, Peptide Analysis

By January 13, 2017

Advancements in High-Resolution Analytics for Characterization of Innovator and Biosimilar Therapeutics Part 2: Peptide Analysis of Infliximab

Categories: Pharmaceutical
Tags: , , , , , ,

How Analytical Technologies Support the Development of Biosimilar Drugs

By January 12, 2017

Advancements in High-Resolution Analytics for the Characterization of Innovator and Biosimilar Therapeutics As the pharmaceutical industry continues to evolve its focus from small-molecule drugs to balanced product portfolios that include protein therapeutics, analytical chemists are… Read more >

Categories: Pharmaceutical
Tags: , , , , , , , , , , ,

Large Molecules Have 2X FDA Approval Rate

By November 23, 2016

It’s no surprise that pharma is Thinking Large. Large molecules are dominating pharma sales and FDA approvals. At the end of 2015, seven of the top 10 best-selling prescription drugs were large molecules. According to a 2014 article… Read more >

Categories: Pharmaceutical
Tags: , , , , , ,

Is using Microflow LC in an Industrial Setting Really that Cumbersome?

By August 30, 2016

Microflow or nanoflow chromatography has been used mostly in the academic and fundamental research environment in the past for its various advantages over analytical liquid chromatography, but rarely in the industrial settings. This is most… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , ,

What Bioanalysis Zone’s New Investigator Award Says About the Future of Science: An Interview with Erin Chambers, PhD

By August 15, 2016

Dr. Erin Chambers is a Director in the Scientific Operations group at Waters Corporation. She recently served as a judge for the Bioanalysis Zone New Investigator Award. I sat down with Erin to gauge her… Read more >

Categories: General, Pharmaceutical
Tags: , , , , ,

In Beverly, the Shoe Fits for Bioanalysis!

By July 20, 2016

This past May, many of the nation’s leading bioanalysts gathered in New England to share ideas and explore the latest advances in mass spectrometry, liquid chromatography, and sample preparation for large molecule quantification. At Waters’… Read more >

Categories: Pharmaceutical
Tags: , ,